164093292	164093292	CD	B-NP	O
|	|	NN	I-NP	O
IHC	IHC	NN	I-NP	O
|	|	NN	I-NP	O
09360461	09360461	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8948221	8948221	CD	B-NP	O
|	|	CC	I-NP	O
1/17/2006	1/17/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/24/2006	2/24/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/15/2006	1/15/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
PAWELEK	PAWELEK	NN	B-NP	B-protein
,	,	,	O	O
BENTON	BENTON	NNP	B-NP	O
FREDERIC	FREDERIC	NNP	I-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
AVR	AVR	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
initially	initially	RB	B-VP	O
presenting	present	VBG	I-VP	O
to	to	TO	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
with	with	IN	B-PP	O
chief	chief	JJ	B-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
exam	exam	NN	I-NP	O
and	and	CC	I-NP	O
laboratory	laboratory	NN	I-NP	O
findings	finding	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
of	of	IN	B-PP	O
747	747	CD	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
I	I	CD	I-NP	O
of	of	IN	B-PP	O
0.43	0.43	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
moderate-to-severe	moderate-to-severe	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
persantine	persantine	JJ	I-NP	O
MIBI	MIBI	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
and	and	CC	O	O
three-vessel	three-vessel	JJ	B-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
distal	distal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
circ	circ	NN	B-NP	O
territory	territory	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
fixed	fixed	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
defect	defect	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Carvedilol	Carvedilol	NN	B-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
.	.	.	O	O

Troponins	Troponin	NNS	B-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
frequent	frequent	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
ectopy	ectopy	NN	B-NP	O
and	and	CC	I-NP	O
SVT	SVT	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Acbroadl	Acbroadl	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
and	and	CC	I-NP	O
possible	possible	JJ	I-NP	O
percutaneous	percutaneous	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
feeling	feel	VBG	I-VP	O
much	much	RB	B-ADJP	O
better	good	JJR	I-ADJP	O
,	,	,	O	O
denied	deny	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
lay	lay	VB	I-VP	O
flat	flat	JJ	B-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
reports	report	VBZ	B-VP	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
climb	climb	VB	I-VP	O
two	two	CD	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
or	or	CC	O	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
poor	poor	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
management	management	NN	I-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
,	,	,	O	O
reports	report	VBZ	B-VP	O
medical	medical	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
,	,	,	O	O
non-ST-wave	non-ST-wave	JJ	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
St.	St.	NNP	B-NP	O
Jude	Jude	NNP	I-NP	O
's	's	POS	B-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
240	240	CD	I-NP	O
sustained	sustained	JJ	I-NP	O
release	release	NN	I-NP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
nystatin	nystatin	NN	B-NP	O
500	500	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Paxil	Paxil	NNP	B-NP	O
20	20	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
10	10	CD	I-NP	O
daily	daily	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
Carvedilol	Carvedilol	NN	B-NP	O
6.25	6.25	CD	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
currently	currently	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
retired	retire	VBN	I-VP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
in	in	IN	B-PP	O
Lin	Lin	NNP	B-NP	O
Con	Con	NNP	I-NP	O
,	,	,	O	O
teaches	teach	VBZ	B-VP	O
graduate	graduate	NN	B-NP	O
courses	course	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
58	58	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
124/60	124/60	CD	I-NP	I-DNA
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
lying	lie	VBG	B-VP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
speaking	speak	VBG	B-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
moist	moist	NN	I-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-NP	O
and	and	CC	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheeze	wheeze	NN	I-NP	O
with	with	IN	B-PP	O
long	long	RB	B-ADVP	O
,	,	,	O	O
pronounced	pronounce	VBD	B-VP	O
expiratory	expiratory	JJ	B-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
prosthetic	prosthetic	JJ	B-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
gallops	gallop	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
and	and	CC	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
are	be	VBP	B-VP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

DP	DP	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Feet	Feet	NN	B-NP	O
are	be	VBP	B-VP	O
cool	cool	JJ	B-ADJP	O
but	but	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
warm	warm	JJ	B-ADJP	O
,	,	,	I-ADJP	O
dry	dry	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
39.5	39.5	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
113	113	CD	B-NP	O
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	B-protein
157	157	CD	I-NP	I-protein
,	,	,	O	O
triglycerides	triglyceride	NNS	B-NP	O
76	76	CD	B-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
110	110	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
6.3	6.3	CD	I-NP	O
,	,	,	O	O
TSH	TSH	NN	B-NP	B-protein
1.9	1.9	CD	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
bundle	bundle	NN	B-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
widened	widen	VBN	I-NP	O
QRS	QRS	NN	I-NP	B-protein
of	of	IN	B-PP	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
190	190	CD	B-NP	O
milliseconds	millisecond	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
cardiomegaly	cardiomegaly	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
NSTEMI	NSTEMI	NN	I-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
through	through	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Elevated	Elevated	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
at	at	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
possibly	possibly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
NSTEMI	NSTEMI	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
versus	versus	IN	B-PP	O
demand	demand	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
effect	effect	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
statin	statin	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
Niaspan	Niaspan	NNP	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
heart	heart	NN	B-NP	O
cath	cath	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
occluded	occlude	VBN	I-VP	O
graft	graft	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
diagonal	diagonal	JJ	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
and	and	CC	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
effused	effuse	VBD	B-VP	O
LIMA	LIMA	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
circumflex	circumflex	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
effused	effuse	VBD	B-VP	O
SVG	SVG	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
stenting	stente	VBG	B-VP	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
V1	V1	NN	I-NP	O
and	and	CC	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
repeat	repeat	NN	B-NP	O
echo	echo	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
MR.	MR.	NN	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
spironolactone	spironolactone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
diuresed	diurese	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
his	his	PRP$	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
and	and	CC	O	O
determine	determine	VB	B-VP	O
the	the	DT	B-NP	O
utility	utility	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
held	hold	VBD	B-VP	O
verapamil	verapamil	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
double	double	JJ	B-NP	O
AV	AV	NN	I-NP	O
nodal	nodal	JJ	I-NP	O
blockade	blockade	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
widened	widen	VBN	B-NP	O
QRS	QRS	NNS	I-NP	B-protein
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
and	and	CC	O	O
SVT	SVT	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
EP	EP	NN	B-NP	B-protein
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
utility	utility	NN	I-NP	O
of	of	IN	B-PP	O
AICD	AICD	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Respiratory	Respiratory	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

Continues	Continue	NNS	B-NP	O
to	to	TO	B-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
residual	residual	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
while	while	IN	B-SBAR	O
lying	lie	VBG	B-VP	O
flat	flat	JJ	B-ADJP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
closely	closely	RB	I-VP	O
follow	follow	VB	I-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
chat	chat	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
pretreated	pretreate	VBN	I-VP	O
with	with	IN	B-PP	O
bicarbonate	bicarbonate	NN	B-NP	O
and	and	CC	I-NP	O
Mucomyst	Mucomyst	NN	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
LFTs	LFT	NNS	B-NP	O
are	be	VBP	B-VP	O
mildly	mildly	RB	I-VP	O
increased	increase	VBN	I-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
39	39	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cath	cath	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
case	case	NN	I-NP	O
and	and	CC	O	O
hemodilution	hemodilution	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
fell	fall	VBD	B-VP	O
to	to	TO	B-PP	O
38	38	CD	B-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
retroperitoneal	retroperitoneal	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
patient	patient	NN	B-NP	O
remaining	remain	VBG	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
groin	groin	NN	B-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
transfused	transfuse	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
and	and	CC	O	O
recently	recently	RB	B-ADJP	O
revascularized	revascularize	VBN	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
guaiac	guaiac	JJ	B-ADJP	O
positive	positive	JJ	B-ADJP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
gross	gross	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
and	and	CC	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
his	his	PRP$	B-NP	O
heparin-bridged	heparin-bridged	JJ	I-NP	B-protein
Coumadin	Coumadin	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
suffers	suffer	VBZ	B-VP	O
from	from	IN	B-PP	O
long-term	long-term	JJ	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
113	113	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Review	Review	NN	B-NP	O
of	of	IN	B-PP	O
records	record	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
on	on	IN	B-PP	O
previous	previous	JJ	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
Norpid	Norpid	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
heparinization	heparinization	NN	B-NP	O
,	,	,	O	O
thus	thus	RB	B-NP	O
low	low	JJ	I-NP	O
suspicion	suspicion	NN	I-NP	O
for	for	IN	B-PP	O
HIT	HIT	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
platelet	platelet	NN	I-NP	O
level	level	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
consider	consider	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
by	by	IN	B-PP	O
Hematology	Hematology	NNP	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	O	O
placed	place	VBN	B-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
discontinuing	discontinue	VBG	B-NP	O
.	.	.	O	O

A1c	A1c	NN	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Paxil	Paxil	NNP	B-NP	O
and	and	CC	I-NP	O
Ativan	Ativan	NNP	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
encouraged	encourage	VBN	I-VP	O
to	to	TO	I-VP	O
stop	stop	VB	I-VP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nicotine	nicotine	NN	I-NP	O
patch	patch	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
prescription	prescription	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
nicotine	nicotine	NN	I-NP	O
patch	patch	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
and	and	CC	I-NP	O
Cardiology	Cardiology	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
EP	EP	NN	B-NP	B-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
encouraged	encourage	VBD	B-VP	O
to	to	TO	I-VP	O
check	check	VB	I-VP	O
his	his	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
report	report	VBP	B-VP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
pounds	pound	NNS	I-NP	O
daily	daily	JJ	B-ADJP	O
or	or	CC	O	O
3	3	CD	B-NP	O
pounds	pound	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
INR	INR	NN	B-NP	O
checks	check	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
With	With	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Qin	Qin	NNP	I-NP	O
,	,	,	O	O
telephone	telephone	NN	B-NP	O
358-190-7457	358-190-7457	CD	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
10/26/06	10/26/06	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
45	45	CD	I-NP	O
,	,	,	O	O
Cardiology	Cardiology	NNP	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mccoyle	Mccoyle	NNP	I-NP	O
at	at	IN	B-PP	O
063-315-1331	063-315-1331	CD	B-NP	O
on	on	IN	B-PP	O
6/2/06	6/2/06	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	SYM	I-NP	O
15	15	CD	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Electrophysiology	Electrophysiology	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Kunich	Kunich	NNP	I-NP	O
on	on	IN	B-PP	O
2/6/06	2/6/06	CD	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
arrange	arrange	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
drawn	draw	VBN	B-VP	O
on	on	IN	B-PP	O
5/29/06	5/29/06	CD	B-NP	O
and	and	CC	O	O
follow-up	follow-up	JJ	B-NP	O
INRs	INR	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INRs	INR	NNS	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Nicotine	Nicotine	NN	B-NP	O
patch	patch	NN	I-NP	O
14	14	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
topical	topical	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Spironolactone	Spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Paxil	Paxil	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Atorvastatin	Atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Niaspan	Niaspan	RB	B-NP	O
0.5	0.5	CD	I-NP	O
gm	gm	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Carvedilol	Carvedilol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Gemfibrozil	Gemfibrozil	NN	B-NP	O
900	900	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-3885395	6-3885395	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SPELMAN	SPELMAN	NN	B-NP	O
,	,	,	O	O
TERENCE	TERENCE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MELVILLE	MELVILLE	NNP	B-NP	O
,	,	,	O	O
GARRETT	GARRETT	NNP	B-NP	O
WALLY	WALLY	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4010844	4010844	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/13/06	6/13/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/13/06	6/13/06	CD	B-NP	O

